UBS Group’s IM Cannabis IMCC Stock Holding History

UBS Group’s Portfolio IMCC Stock Details IMCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Hold	0	–	–	–	10384
2026 Q1	–	Hold	0	–	–	–	10388
2025 Q4	–	Hold	0	–	–	–	10409
2025 Q3	–	Hold	0	–	–	–	10223
2025 Q2	–	Hold	0	–	–	–	10163
2023 Q1	–	Hold	0	–	-$2	–	9942
2022 Q4	–	Hold	0	–	–	–	10646
2021 Q4	–	Sell	-2	Closed	-$12K	–	10464
2021 Q3	$12K	Buy	+2	New	+$15.2K	﹤0.01%	7764

Other funds holding IMCC

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

HCWM

Hidden Cove Wealth Management Bainbridge Island, Washington $182M AUM 24.56% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

UBS Group's IMCC Position: Q2 2026 in Review

UBS Group held its IM Cannabis (IMCC) position steady in Q2 2026 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #10384.

UBS Group first reported a position in IMCC in Q3 2021 and has held it in 1 quarter since. The position peaked at $12K in Q3 2021. 10 funds tracked by Wall St. Rank hold IMCC as of Q2 2026.

UBS Group held 0 shares of IM Cannabis worth $1 as of Q2 2026.
UBS Group left its IM Cannabis share count unchanged in Q2 2026.
IM Cannabis made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10384 holding.
UBS Group first reported a position in IM Cannabis in Q3 2021 and has held it in 1 quarter since.
UBS Group's IM Cannabis position peaked at $12K in Q3 2021.
10 funds tracked by Wall St. Rank held IM Cannabis as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.